Toshihide Naganuma
Overview
Explore the profile of Toshihide Naganuma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
404
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Masuda K, Naganuma T, Torigoe T, Kabei K, Machida Y, Iwai T, et al.
Transplant Proc
. 2024 Mar;
56(3):750-753.
PMID: 38472084
Background: In the use of therapeutic plasma exchange (TPE) as antibody removal therapy for ABO-incompatible (ABOi) kidney transplantation, it is technically possible to perform online hemodiafiltration (OHDF) and TPE simultaneously...
2.
Naganuma T, Kuroki Y, Iwai T, Takemoto Y, Uchida J
Transplant Proc
. 2024 Feb;
56(3):526-529.
PMID: 38395661
Backgrounds: There are advantages and disadvantages with closure of an arteriovenous fistula (AVF) after kidney transplantation, but some cases require closure. The general procedure for closure is angioplasty with exposure...
3.
Machida Y, Iwai T, Kabei K, Naganuma T, Uchida J
Transplant Proc
. 2024 Feb;
56(3):534-539.
PMID: 38355374
Background: Daprodustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor, has been reported to be effective in treating conservative renal failure and renal anemia in patients undergoing dialysis. However, its effects on...
4.
Morioka F, Nakatani S, Mori K, Naganuma T, Yamasaki T, Uedono H, et al.
Intern Med
. 2024 Feb;
63(18):2537-2541.
PMID: 38346741
Thirteen years after kidney donation, a 70-year-old man was referred to a nephrologist because of proteinuria. The serum creatinine, albumin, and urinary protein levels were 2.39 mg/dL, 3.0 g/dL, and...
5.
Naganuma T, Takemoto Y, Kamada N, Kabata D, Shintani A, Ota K, et al.
Blood Purif
. 2024 Feb;
53(6):527-532.
PMID: 38310867
Introduction: Recent advances in dialysis therapy have made it possible to remove middle molecules. Removal of small-middle molecules, such as β2-microglobulin, can now be achieved with conventional hemodialysis (HD), and...
6.
Sakurada T, Kojima S, Yamada S, Koitabashi K, Taki Y, Matsui K, et al.
Perit Dial Int
. 2023 Aug;
43(6):457-466.
PMID: 37632293
Background: This multi-institutional, observational study examined whether the outcomes after peritoneal dialysis (PD) catheter placement in Japan meet the audit criteria of the International Society for Peritoneal Dialysis (ISPD) guideline...
7.
Kabei K, Iwai T, Kosoku A, Nishide S, Iguchi K, Machida Y, et al.
Transplant Proc
. 2023 Jul;
55(8):1910-1912.
PMID: 37524583
The patient, a 54-year-old woman, underwent a living donor kidney transplant at Osaka City University Hospital 7 years before the bariatric surgery. Her comorbidities were diabetes, sleep apnea, and severe...
8.
Nov T, Hyodo T, Kitajima Y, Kokubo K, Naganuma T, Wakai H, et al.
Ren Replace Ther
. 2022 Jun;
8(1):27.
PMID: 35729886
[This retracts the article DOI: 10.1186/s41100-021-00372-6.].
9.
Naganuma T, Iwai T, Takemoto Y, Uchida J
Transplant Proc
. 2022 Feb;
54(2):544-548.
PMID: 35120763
In this study, we report on an experience with the use of a novel agent "roxadustat," a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), for posttransplant anemia (PTA) in renal transplant...
10.
Nov T, Hyodo T, Kitajima Y, Kokubo K, Naganuma T, Wakai H, et al.
Ren Replace Ther
. 2021 Oct;
7(1):53.
PMID: 34659800
Cambodia detected its first case of COVID-19 just 3 days before WHO declared that the outbreak constituted as PHEIC. As of February 15, 2021, and after two major outbreaks, only...